Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

32.28
+1.023.25%
Post-market: 32.500.2250+0.70%19:30 EDT
Volume:1.29M
Turnover:41.54M
Market Cap:2.31B
PE:-5.47
High:32.97
Open:31.42
Low:31.03
Close:31.26
52wk High:56.05
52wk Low:21.15
Shares:71.71M
Float Shares:62.80M
Volume Ratio:0.52
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.68
PE(LYR):-6.92

Loading ...

Vera Therapeutics, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Vera Therapeutics Q1 EPS $(1.69) Misses $(1.34) Estimate

Benzinga Earnings
·
May 07

Vera Therapeutics Q1 net loss widens to $121.03 million

Reuters
·
May 07

BRIEF-Vera Therapeutics Q1 EPS USD -1.69 Vs. IBES Estimate USD -1.33

Reuters
·
May 07

Vera Therapeutics, Inc - U.S. Commercial Launch of Atacicept Expected Mid-2026, Pending Approval

THOMSON REUTERS
·
May 07

Vera Therapeutics, Inc - $596.8 Mln in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2026

THOMSON REUTERS
·
May 07

Press Release: Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Vera Therapeutics to present at Bank of America Securities 2026 Health Care Conference

Reuters
·
May 04

Vera CEO Marshall Fordyce disposes of Vera Therapeutics shares worth $1,018,054

Reuters
·
Apr 16

BRIEF-Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 11

Vera Therapeutics grants inducement awards to 89 hires, issuing 258,200 options and 131,925 RSUs

Reuters
·
Apr 11

Vera Therapeutics announces annual shareholder meeting

Reuters
·
Apr 10

Vera Therapeutics grants 56,850 stock options at $40.73; issues 42,403 RSUs under 2024 Inducement Plan

Reuters
·
Mar 28

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 28

Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer

Reuters
·
Mar 25

Analysts Conflicted on These Healthcare Names: Cochlear (OtherCHEOF), Universal Health (UHS) and Vera Therapeutics (VERA)

TIPRANKS
·
Mar 17

Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears

Simply Wall St.
·
Mar 16

Vera Therapeutics Raised to Outperform From Peer Perform by Wolfe Research

Dow Jones
·
Mar 11

Vera Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research

TIPRANKS
·
Mar 11

Vera Therapeutics appoints Christopher Hite to board

Reuters
·
Mar 10